|
42. |
Zuberbier, T., Dörr, T., Grattan, C., and Maurer, M.: Omalizumab in the treatment of urticaria. In: Zuberbier, T. Grattan, C., and Maurer, M., editors: Urticaria and Angioedema. 2nd ed., Switzerland: Springer, 2021 |
bc.42
|
173. |
Zhao, Z.+, Cai, T., Chen, H., Chen, L., Chen, Y., Gao, X., Gao, X., Geng, S., Guo, Y., Hao, F., Hao, G., Hu, Y., Jin, H., Jin, Z., Li, C., Li, H., Li, J., Li, Y., Liang, Y., Liu, G., Liu, Q., Long, H., Ma, L., Shang, Y., Song, Y., Song, Z., Su, X., Sui, H., Sun, Q., Sun, Y., Tang, J., Tong, X., Wang, H., Wang, G., Wang, L., Wang, S., Xiang, L., Xiao, T., Xie, Z., Ye, L., Yu, Y., Zhang, C., Zhang, L., Zhang, S., Zheng, R., Zhi, L., Zhou, W., Zou, Y., and Maurer, M.+: Expert consensus on the use of omalizumab in chronic urticaria in China. World Allergy Organ. J. 2021: 14; e100610. IF: 5.52 |
r.173
| 171. | Bachert, C.+, Maurer, M., Palomares, O., and Busse, W. W.: What is the contribution of IgE to nasal polyposis? J. Allergy Clin. Immunol. 2021: 147; 1997-2008. IF: 14.29 |
r.171
| 427. | Skander, D., Allenova, A., Maurer, M., and Kolkhir, P.+: Omalizumab is effective in patients with chronic spontaneous urticaria plus multiple chronic inducible urticaria. Eur. Ann. Allergy Clin. Immunol. 2021: 53; 91-93. IF: N/A |
o.427
| 423. | Song, X., Chen, Y.-D., Yu, M., Liu, B., Zhao, Z. T.+, and Maurer, M.+: Omalizumab in children and adolescents with chronic urticaria: a 16 week real-world study. Allergy 2021: 76; 1271-1273. IF: 14.71 |
o.423
| 421. | Yu, M., Terhorst-Molawi, D., Altrichter, S., Hawro, T., Chen, Y.-D., Liu, B., Song, X.-T., Zhao, Z.+*, and Maurer, M.+*: Omalizumab in chronic inducible urticaria: a real-life study of efficacy, safety, predictors of treatment outcome and time to response. Clin. Exp. Allergy 2021: 51; 730-734. IF: 5.40 |
o.421
|
169. |
Maurer, M.+, Khan, D. A., Komi, D. E. A., and Kaplan, A. P.: Biologics for the use in chronic spontaneous urticaria: when and which? J. Allergy Clin. Immunol. Pract. 2021: 9; 1067-1078. IF: 11.02 |
r.169
| 419. | Bauer, A., Dickel, H., Jakob, T., Kleinheinz, A., Lippert, U., Metz, M., Schliemann, S., Schwichtenberg, U., Staubach, P., Valesky, E., Wagner, N., Wedi, B., and Maurer, M.+: Expert consensus on practical aspects in the treatment of chronic urticaria. Allergo J. Int. 2021. 30; 64-75. IF: N/A |
o.419
| 417. | Liao, S. L., Yu, M., Zhao, Z.*, and Maurer, M.+*: Case Report: Omalizumab for chronic spontaneous urticaria in pregnancy. Front. Immunol. 2021: 12; 652973. IF: 8.79 |
o.417
| 415. | Kocatürk, E.+, Salman, A., Cherrez-Ojeda, I., Criado, P. R., Peter, J., Comert-Ozer, E., Abuzakouk, M., Agondi, C. R., Al-Ahmad, M., Altrichter, S., Arnaout, R., Arruda, K. L., Asero, R., Bauer, A., Ben-Shoshan, M., Bernstein, J. A., Bizjak, M., Boccon-Gibod, I., Bonnekoh, H., Bouillet, L., Brzoza, Z., Busse, P., Campos, R. A., Carne, E., Conlon, N., Criado, R. F., de Souza Lima, E. M., Demir, S., Dissemond, J., Doğan Günaydın, S., Dorofeeva, I., Ensina, L. F., Ertaş, R., Ferrucci, M. S., Figueras-Nart, I., Fomina, D., Franken, S. M., Fukunaga, A., Giménez-Arnau, A. M., Godse, K., Gonçalo, M., Gotua, M., Grattan, C., Guillet, C., Inomata, N., Jakob, T., Karakaya, G., Kasperska-Zając, A., Katelaris, C. H., Košnik, M., Krasowska, D., Kulthanan, K., Kumaran, S. M., Lang, C., Larco-Sousa, J. I., Lazaridou, E., Leslie, T. A., Lippert, U., Llosa, O. C., Makris, M., Marsland, A., Medina, I. V., Meshkova, R., Palitot, E. B., Parisi, C. A. S., Pickert, J., Ramon, G.D., Rodríguez-Gonzalez, M., Rosario, N., Rudenko, M., Rutkowski, K., Sánchez, J., Schliemann, S., Sekerel, B. E., Serpa, F. S., Serra-Baldrich, E., Song, Z., Soria, A., Staevska, M., Staubach, P., Tagka, A., Takahagi, S., Thomsen, S. F., Treudler, R., Vadasz, Z., Valle, S. O. R., Van Doorn, M. B. A., Vestergaard, C., Wagner, N., Wang, D., Wang, L., Wedi, B., Xepapadaki, P., Yücel, E., Zalewska-Janowska, A., Zhao, Z., Zuberbier, T., and Maurer, M.+: The global impact of the COVID-19 pandemic on the management and course of chronic urticaria. Allergy 2021: 76; 816-830. IF: 14.71 |
o.415